Latest Headlines

Latest Headlines

GE-backed deep learning startup Arterys bumps up Series A to $12M+ as it nears cardio launch, goes into oncology

Medical imaging deep learning startup Arterys has a major partnership with GE and a cardio product launch teed up as part of that for this fall. Now, it's lined up a more than $12 million Series A financing to help it transition into its next field: oncology. The San Francisco, CA-based startup had previously disclosed a smaller sum for that Series A of $7 million late last year.

St. Jude team creates tool to visualize pediatric cancer mutations

A team at St. Jude Children's Research Hospital has created a tool to visualize the mutations that lead to pediatric cancers. The free application, called ProteinPaint, displays genetic lesions such as sequence mutations and gene fusion alongside RNA expression.

CRUK adds 3-D protein structures to cancer-focused drug discovery database

Cancer Research UK has unveiled version 3.0 of its oncology drug discovery database. The latest iteration of the platform contains more than 110,000 3-D structures for nearly 22,000 proteins, a resource the team behind the database thinks will support improved target selection.

Drug costs soar as China tops world ranking in cancer

As World Health Organization figures show China rising to the top of the list of countries with the most cancer cases, its people are facing increasing problems in trying to find ways to pay for their treatments. Healthcare costs are soaring in the nation despite the government's efforts to force drug prices lower.

China's Kelun Pharma opens $50M Kazakhstan plant for intravenous oncology drugs

China's Kelun Pharmaceutical has just opened a $50 million production plant in Almaty (formerly Alma-Ata), just across the border in Kazakhstan. Kelun Kazpharm executives told China's state-run Xinhua news agency the plant is responsible for 70% of the Kazakhstan market for intravenous medicines.

Lee's Pharma affiliate licenses Tragara's TG02 oncology treatment for much of Asia

An affiliate of Hong Kong-listed Lee's Pharmaceutical Holdings has licensed the TG02 oncology treatment developed by California-based Tragara Pharmaceuticals, the companies said in a statement.

Boston Sci moves deeper into oncology with $70M+ purchase from CeloNova

Cardiovascular-focused Boston Scientific is moving deeper into oncology and expanding its vascular offerings with the purchase of the interventional radiology portfolio of CeloNova BioSciences. The deal with the San Antonio, TX-based startup involves a $70 million upfront payment with additional, undisclosed regulatory and sales milestones.

NEA backs cancer genome Dx startup Personal Genome in $21M+ Series A

Another startup is emphatically advancing into the fray to elicit and apply genomic data as a guide for cancer diagnoses and treatment. Personal Genome Diagnostics has raised a $21.4 million Series A round to expand its commercial genomic oncology testing service.

China's Innovent Biologics deepens pact with Eli Lilly on immuno-oncology

China's Innovent Biologics has deepened a pact with Eli Lilly by including immuno-oncology bispecific antibodies for Innovent in Greater China and for the Indianapolis-based firm outside of the country, setting a new benchmark in a white-hot area of collaboration deals.

Stealth startup Onkos gets Series A, partnership for next-gen bone cancer surgery

Onkos Surgical has secured a Series A financing and partnered with MicroPort Orthopedics. The financial details were undisclosed in the company's announcement, but an SEC filing reveals that Onkos recently secured the first $6.1 million of a financing that's expected to total $15.3 million.
  • 1
  • 2
  • 3
  • 4
  • next ›
  • last »